Boule Diagnostics AB (BOUL) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.017x

Based on the latest financial reports, Boule Diagnostics AB (BOUL) has a cash flow conversion efficiency ratio of -0.017x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-2.70 Million ≈ $-290.56K USD) by net assets (Skr161.50 Million ≈ $17.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Boule Diagnostics AB balance sheet independence to measure how much of total assets are equity-financed.

Boule Diagnostics AB - Cash Flow Conversion Efficiency Trend (2005–2024)

This chart illustrates how Boule Diagnostics AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Boule Diagnostics AB cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Boule Diagnostics AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Boule Diagnostics AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
HEC Infra Projects Limited NSE:HECPROJECT	0.067x
Hanwha Investment&Securities Co Ltd Pref KO:003535	-0.112x
Korean Air Lines Co Ltd KO:003495	0.185x
Trinity Biotech plc NASDAQ:TRIB	0.001x
Ping An Biomedical Co., Ltd. NASDAQ:PASW	N/A
Cheetah Holdings Bhd KLSE:7209	-0.096x
Nuriplan Co. Ltd KQ:069140	0.043x
Bharat Road Network Limited NSE:BRNL	-0.109x

Annual Cash Flow Conversion Efficiency for Boule Diagnostics AB (2005–2024)

The table below shows the annual cash flow conversion efficiency of Boule Diagnostics AB from 2005 to 2024. For the full company profile with market capitalisation and key ratios, see BOUL company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr269.60 Million ≈ $29.01 Million	Skr46.60 Million ≈ $5.01 Million	0.173x	+59.84%
2023-12-31	Skr475.10 Million ≈ $51.13 Million	Skr51.38 Million ≈ $5.53 Million	0.108x	+540.55%
2022-12-31	Skr462.50 Million ≈ $49.77 Million	Skr-11.35 Million ≈ $-1.22 Million	-0.025x	-116.77%
2021-12-31	Skr295.74 Million ≈ $31.83 Million	Skr43.28 Million ≈ $4.66 Million	0.146x	-47.61%
2020-12-31	Skr269.30 Million ≈ $28.98 Million	Skr75.24 Million ≈ $8.10 Million	0.279x	+72.30%
2019-12-31	Skr332.87 Million ≈ $35.82 Million	Skr53.98 Million ≈ $5.81 Million	0.162x	+115.26%
2018-12-31	Skr300.86 Million ≈ $32.38 Million	Skr22.66 Million ≈ $2.44 Million	0.075x	-65.83%
2017-12-31	Skr261.77 Million ≈ $28.17 Million	Skr57.72 Million ≈ $6.21 Million	0.220x	+154.89%
2016-12-31	Skr229.76 Million ≈ $24.73 Million	Skr19.88 Million ≈ $2.14 Million	0.087x	-26.95%
2015-12-31	Skr188.51 Million ≈ $20.29 Million	Skr22.32 Million ≈ $2.40 Million	0.118x	-35.03%
2014-12-31	Skr169.99 Million ≈ $18.29 Million	Skr30.98 Million ≈ $3.33 Million	0.182x	+48.25%
2013-12-31	Skr127.49 Million ≈ $13.72 Million	Skr15.68 Million ≈ $1.69 Million	0.123x	+124.26%
2012-12-31	Skr199.69 Million ≈ $21.49 Million	Skr10.95 Million ≈ $1.18 Million	0.055x	+94.22%
2011-12-31	Skr192.86 Million ≈ $20.75 Million	Skr5.44 Million ≈ $585.86K	0.028x	-77.19%
2010-12-31	Skr130.56 Million ≈ $14.05 Million	Skr16.16 Million ≈ $1.74 Million	0.124x	+52.21%
2009-12-31	Skr100.89 Million ≈ $10.86 Million	Skr8.20 Million ≈ $882.84K	0.081x	+117.31%
2008-12-31	Skr115.22 Million ≈ $12.40 Million	Skr4.31 Million ≈ $463.92K	0.037x	-78.30%
2005-12-31	Skr132.36 Million ≈ $14.24 Million	Skr22.82 Million ≈ $2.46 Million	0.172x	--

About Boule Diagnostics AB

ST:BOUL Sweden Medical Devices

Market Cap

$15.88 Million

Skr147.57 Million SEK

Market Cap Rank

#25779 Global

#533 in Sweden

Share Price

Skr3.80

Change (1 day)

-0.52%

52-Week Range

Skr3.15 - Skr6.48

All Time High

Skr74.05